SCHEMBL6735845

SCHEMBL6735845

CN(C)c1cc(C(=O)O)sc1[N+](=O)[O-]

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
HCAR3 P49019 4/20 0.46
KDM4E B2RXH2 3/20 0.39
GLA P06280 1/20 0.39
DAO P14920 3/20 0.38
KMT2A Q03164 3/20 0.38
MAPT P10636 2/20 0.38
MEN1 O00255 1/20 0.38
HTT P42858 3/20 0.36
GPR35 Q9HC97 1/20 0.35
HPGD P15428 2/20 0.35
NPC1 O15118 1/20 0.35
LMNA P02545 1/20 0.35
MAPK1 P28482 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TP53 P04637 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29016889 0.77 DAO (0.55) ALDH1A1KDM4EGLADAOKMT2A
SCHEMBL15562641 0.74 DAO (0.55) ALDH1A1KDM4EDAOKMT2AMAPT
SCHEMBL6508901 0.74 DAO (0.38) ALDH1A1KDM4EDAOKMT2AMAPT
SCHEMBL6198173 0.72 ALDH1A1 (0.35) ALDH1A1HCAR3KDM4EKMT2AMAPT
SCHEMBL20894369 0.72 DAO (0.58) ALDH1A1KDM4EDAOKMT2AMAPT
SCHEMBL11662256 0.70 GPR35 (0.53) HCAR3KMT2AMAPTMEN1HTT
SCHEMBL1242736 0.67 DAO (0.55) ALDH1A1HCAR3KDM4EDAOKMT2A
SCHEMBL2866199 0.65 MAPT (0.39) ALDH1A1HCAR3KDM4EDAOKMT2A
SCHEMBL2866197 0.65 MAPT (0.39) ALDH1A1HCAR3KDM4EDAOKMT2A
SCHEMBL3230116 0.65 CA1 (0.43) ALDH1A1HCAR3KDM4EDAOKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040242591-A1 Oxazolidinone derivatives as pontential antimicrobials RANBAXY LABORATORIES LIMITED (IN) 2004-12-02 US disclosed
EP-1409464-A1 OXAZOLIDINONE DERIVATIVES AS POTENTIAL ANTIMICROBIALS RANBAXY LABORATORIES, LTD. (IN) 2004-04-21 EP disclosed
WO-2003008389-A1 OXAZOLIDINONE DERIVATIVES AS POTENTIAL ANTIMICROBIALS RANBAXY LABORATORIES LIMITED (IN) 2003-01-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040242591-A1 Oxazolidinone derivatives as pontential antimicrobials PDK4, OXA1L, PPARD ALDH1A1 1234/4885HCAR3 3170/4885KDM4E 2049/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.